Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) will issue its quarterly earnings data after the market closes on Wednesday, April 24th. Analysts expect the company to announce earnings of $0.16 per share for the quarter. Core Laboratories has set its Q1 2024 guidance at 0.140-0.180 EPS and its Q1 guidance at $0.14-0.18 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, January 31st. The oil and gas company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). Core Laboratories had a net margin of 8.03% and a return on equity of 15.19%. The firm had revenue of $128.21 million during the quarter, compared to analysts’ expectations of $127.80 million. During the same quarter last year, the business earned $0.23 earnings per share. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Performance

NYSE:CLB opened at $16.96 on Tuesday. The firm’s fifty day moving average price is $16.15 and its 200 day moving average price is $17.72. Core Laboratories has a 1-year low of $13.82 and a 1-year high of $27.94. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.53 and a quick ratio of 1.72. The firm has a market cap of $794.75 million, a price-to-earnings ratio of 19.72, a price-to-earnings-growth ratio of 0.97 and a beta of 2.40.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 4th. Shareholders of record on Monday, February 12th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend was Friday, February 9th. Core Laboratories’s dividend payout ratio (DPR) is currently 4.65%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CLB shares. Stifel Nicolaus cut their price target on Core Laboratories from $21.00 to $17.00 and set a “hold” rating for the company in a research note on Monday, February 5th. Bank of America cut their price target on Core Laboratories from $17.00 to $16.00 and set an “underperform” rating for the company in a research note on Monday, April 15th. Finally, StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, January 20th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $18.50.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.